Status:
UNKNOWN
Personalised Exercise Training in Adolescents With Type 2 Diabetes for the Early Prevention of Beta Cell Dysfunction
Lead Sponsor:
Yasemin Çırak
Collaborating Sponsors:
Istinye University
Conditions:
Type 2 Diabetes
Eligibility:
All Genders
10-19 years
Phase:
NA
Brief Summary
Exercise training is a key component in the prevention and treatment of various chronic diseases such as Type 2 diabetes (T2DM). Adaptations and effects that occur with exercise training differ accord...
Detailed Description
Diabetes Mellitus (DM) is a metabolic disease characterized by hyperglycemia due to insulin secretion or insufficiency in insulin function. In Type 2 diabetes (T2DM), the most common type of DM, high ...
Eligibility Criteria
Inclusion
- Diagnosed with T2DM,
- Being between the ages of 10-19,
- Body mass index (BMI) below 40 kg/m2,
- Being able to cooperate and walk for the exercise training and evaluation methods.
Exclusion
- Having type 1 diabetes,
- Known lung disease,
- Have had any cardiac event or surgery in the last six months,
- Diabetes complications such as nephropathy, retinopathy and severe neuropathy,
- Being on insulin therapy,
- Having a known cancer disease,
- Having a known autoimmune, rheumatological disease,
- Having any known neuromuscular disease,
- Having other known endocrine disease other than T2DM,
- Existence of limitations and diseases that may affect exercise training.
Key Trial Info
Start Date :
December 1 2022
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
December 1 2024
Estimated Enrollment :
120 Patients enrolled
Trial Details
Trial ID
NCT05344768
Start Date
December 1 2022
End Date
December 1 2024
Last Update
April 25 2022
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.